<DOC>
	<DOCNO>NCT00373841</DOCNO>
	<brief_summary>The purpose study identify genetic biologic marker may predict loss lung function due idiopathic pulmonary fibrosis . The study compare genetic biologic marker sample change symptom . The ultimate goal predict patient likely experience rapid decline lung function due disease progression .</brief_summary>
	<brief_title>Genomic Proteomic Analysis Disease Progression Idiopathic Pulmonary Fibrosis ( IPF )</brief_title>
	<detailed_description>People diagnose idiopathic pulmonary fibrosis ask participate study . The subject must treat Dorothy P. Richard P. Simmons Center Interstitial Lung Disease . Subjects , consent , require perform test research data collect . At initial visit , patient subject blood draw , pulmonary function testing , echocardiogram , CT scan well complete several questionnaire design measure patient feeling . Follow visit schedule 3-4 month interval . Every 3-4 month blood sample collect every 6-8 month questionnaire administer . If patient enters stage accelerated decline lung function , bronchoscopy perform collect residual bronchoalveolar lavage fluid test . All result clinical laboratory testing place subject research file .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Disease Progression</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
	<criteria>Patients 18 old Diagnosis Idiopathic Pulmonary Fibrosis Treated Simmons Center Other Lung Illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Lung</keyword>
	<keyword>Fibrosis</keyword>
	<keyword>Idiopathic</keyword>
	<keyword>Biomarkers</keyword>
	<keyword>Genomics</keyword>
	<keyword>Longitudinal</keyword>
</DOC>